TXNDC12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.852200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.751600E-01
Normal-vs-Stage2
6.509800E-01
Normal-vs-Stage3
4.769400E-01
Normal-vs-Stage4
2.036200E-01
Stage1-vs-Stage2
3.841200E-01
Stage1-vs-Stage3
5.162200E-01
Stage1-vs-Stage4
1.055150E-01
Stage2-vs-Stage3
1.293040E-01
Stage2-vs-Stage4
1.198580E-01
Stage3-vs-Stage4
7.377700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.131400E-01
Normal-vs-AfricanAmerican
6.440800E-01
Normal-vs-Asian
5.541200E-01
Caucasian-vs-AfricanAmerican
8.152600E-01
Caucasian-vs-Asian
4.934400E-01
AfricanAmerican-vs-Asian
8.334400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.192600E-01
Normal-vs-Female
5.313200E-01
Male-vs-Female
1.615160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.635200E-01
Normal-vs-Age(41-60Yrs)
2.811200E-01
Normal-vs-Age(61-80Yrs)
8.509200E-01
Normal-vs-Age(81-100Yrs)
7.864400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.224400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.922800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.353200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.381570E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.971390E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.042400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.224600E-01
Normal-vs-Daily Drinker
9.077400E-01
Normal-vs-Weekly Drinker
7.741200E-01
Normal-vs-Occasional Drinker
2.463400E-01
Normal-vs-Social Drinker
4.018800E-01
Non Drinker-vs-Daily Drinker
9.816800E-01
Non Drinker-vs-Weekly Drinker
5.419000E-01
Non Drinker-vs-Occasional Drinker
1.205580E-01
Non Drinker-vs-Social Drinker
3.214200E-01
Daily Drinker-vs-Weekly Drinker
4.788200E-01
Daily Drinker-vs-Occasional Drinker
9.140100E-02
Daily Drinker-vs-Social Drinker
2.927800E-01
Weekly Drinker-vs-Occasional Drinker
2.074400E-02
Weekly Drinker-vs-Social Drinker
8.159600E-02
Occasional Drinker-vs-Social Drinker
5.079600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.093400E-01
Normal-vs-Grade 2
7.923000E-01
Normal-vs-Grade 3
8.092600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.021600E-02
Grade 1-vs-Grade 3
8.766000E-02
Grade 1-vs-Grade 4
9.093400E-01
Grade 2-vs-Grade 3
6.968400E-01
Grade 2-vs-Grade 4
7.923000E-01
Grade 3-vs-Grade 4
8.092600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.394600E-01
Normal-vs-NonDiabetic
6.594000E-01
Diabetic-vs-NonDiabetic
4.283000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.894400E-01
Normal-vs-NoPancreatitis
7.607800E-01
Pancreatitis-vs-NoPancreatitis
5.332400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.276000E-01
Normal-vs-N1
6.510400E-01
N0-vs-N1
7.861400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.362200E-01
Normal-vs-TP53-NonMutant
6.500400E-01
TP53-Mutant-vs-TP53-NonMutant
5.837900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
